U.S. Life Sciences Stock News

Blackstone Mortgage Trust (BXMT) is back on investors’ radar after recent share price moves, with the stock closing at US$16.64. The company’s latest performance is drawing attention to its commercial real estate lending focus. See our latest analysis for Blackstone Mortgage Trust. Over the past few months, Blackstone Mortgage Trust’s share price return has trended lower, with the stock down 4.53% over 30 days and 12.79% over 90 days, while the 1-year total shareholder return declined 4.92%...

Shares of Baxter International (BAX) moved higher in the latest session after TD Cowen lifted its valuation outlook on the stock while keeping a neutral rating, drawing fresh attention to the healthcare supplier. See our latest analysis for Baxter International. The TD Cowen revision comes after a strong run in Baxter International's share price, with a 90 day share price return of 44.20% and a year to date share price return of 24.97%. However, the 1 year total shareholder return has...

Recent commentary around Brookfield Infrastructure Partners (NYSE:BIP) has focused on its exposure to power hungry AI data centers and other essential infrastructure, with upbeat sentiment building ahead of the partnership’s upcoming earnings report. See our latest analysis for Brookfield Infrastructure Partners. The recent run in Brookfield Infrastructure Partners’ share price, with a 30 day share price return of 14.56% and a year to date share price return of 22.24%, adds to a 1 year total...

Amgen stock has delivered an 88.5% total return over the past five years, and the latest Discounted Cash Flow (DCF) estimate currently points to the shares trading at a 43.0% discount to intrinsic value, while broader valuation checks paint a more mixed picture. Over five years, Amgen has returned 88.5%, which puts current investors in a strong position and raises the question of how much of the story is already reflected in the share price. Management confidence around a broad portfolio of...

AXT (AXTI) heads into its second quarter 2026 earnings report on July 30, with investor attention centered on AI related demand, a record indium phosphide backlog and recent manufacturing expansion. See our latest analysis for AXT. AXT’s share price has pulled back sharply in recent weeks, with a 1 day share price return of down 10.69% and a 30 day share price return of down 39.04%. However, the year to date share price return of 155.13% and a very large 1 year total shareholder return...

PBF Energy was recently highlighted as a leading low‑beta U.S. refiner, with strong refinery utilization helping it serve resilient fuel demand despite elevated oil input costs. This focus on PBF’s role in meeting steady U.S. demand while managing higher feedstock prices underscores how its refining operations may help buffer cost pressures. We’ll now examine how PBF’s positioning as a leading low‑beta refiner amid resilient U.S. demand may influence its investment narrative. Rare earth...

On July 14, 2026, C3.ai, Inc. reported that a U.S. federal court dismissed in full a putative securities class action lawsuit filed against the company and certain officers in August 2025, removing all asserted causes of action. This legal outcome lifts a significant source of uncertainty around potential litigation exposure and compliance concerns that had been hanging over C3.ai’s operations and governance. With the securities lawsuit dismissed, we’ll examine how reduced legal overhang...

FDA has approved Freenome's SimpleScreen blood-based colorectal cancer test for average-risk adults. Abbott Laboratories, NYSE:ABT, holds exclusive rights to commercialize SimpleScreen in the U.S. This agreement expands Abbott's colorectal cancer screening portfolio and strengthens its role in blood-based diagnostics. Abbott Laboratories, NYSE:ABT, is moving into a higher profile position in colorectal cancer screening through this new U.S. commercialization partnership for SimpleScreen...

Biohaven (BHVN) is back in focus after a federal jury found that Avilar Therapeutics and RA Capital Management willfully misappropriated trade secrets tied to its licensed MODA protein degradation platform, awarding damages to Biohaven and Yale University. See our latest analysis for Biohaven. Following the verdict, Biohaven's share price has eased in the very short term, with a 1-day share price return of 5.10% decline and a 7-day share price return of 11.22% decline. However, the 90-day...

Dolby Laboratories stock has had a tough run over the past few years, yet the valuation checks currently lean cheap and suggest the market may be pricing the business more pessimistically than those checks imply. Over the last 5 years, shareholders have seen the stock decline 43.1%, which points to a long stretch of weak returns that may already reflect a lot of caution. Future demand for Dolby Laboratories' audio and imaging technologies can support the case for the current price, while any...

The US Bureau of Economic Analysis is about to tweak how it measures the Fed’s preferred inflation gauge, the PCE index, and that could subtly shift how markets think about interest rates. A small downward adjustment to recent inflation readings may ease some pressure on future rate hikes, which often matters for growth oriented technology stocks with long term earnings stories. At the same time, debate around the timing and transparency of the change may keep volatility alive. This article...

Boeing stock jumped 4.8% to US$221.56 today, even as the headline print was another quarterly loss. The market cheered the cash story instead of the earnings line. Revenue for the second quarter came in at US$24.6b and free cash flow turned positive at US$631m, which matters far more for a heavily indebted manufacturer than a single quarter of earnings per share. Short term traders are reacting to relief. Long term investors will be weighing that fresh cash generation against a still heavy...

On July 15, 2026, Celsius Holdings refinanced its term loan facility, replacing a US$700.00 million loan with a new US$694.75 million term loan at a 0.25% lower interest rate, with the possibility of a further 0.25% reduction tied to credit ratings, while keeping its revolving facility terms unchanged and avoiding prepayment penalties. This refinancing slightly lowers Celsius’s borrowing costs and introduces an incentive to maintain stronger credit ratings, which could support financial...

NRG Energy (NRG) reaffirmed its capital return approach on July 22, 2026, by declaring a quarterly dividend of US$0.4750 per share, payable August 17, with an ex dividend and record date of August 3. See our latest analysis for NRG Energy. Despite reaffirming its dividend, NRG Energy’s recent share price performance has been weak, with the stock at US$127.56 and the 30 day share price return down 14.6%. The 1 year total shareholder return remains strongly positive over the longer 3 and 5 year...

Cheniere Energy stock has delivered a very strong 207.0% return over the past 5 years, yet its low value score and broadly about-right market pricing raise questions about how much upside may still be left in the current valuation. Over 5 years, Cheniere Energy has returned 207.0%. This puts recent gains front and center when judging whether the current share price leaves much margin for error. Management focus on long term growth and shareholder value, set against the reality of global LNG...

Skyworks Solutions (NasdaqGS:SWKS) has suspended its dividend following weaker quarterly results. The company has authorized a new share repurchase program of up to US$2b. These moves mark a shift in how Skyworks is prioritizing cash returns to shareholders. Skyworks Solutions supplies analog and mixed signal semiconductors that sit inside smartphones, connected devices and a range of radio frequency applications. The company operates in markets tied to wireless connectivity and data usage,...

Tesla (TSLA) just signed a new long term power purchase agreement with Zelestra for the 140 MWac Lumen Farm solar project in northeast Texas, adding to its growing renewable energy commitments across key markets. See our latest analysis for Tesla. Tesla shares have come under pressure recently, with the 7 day share price return down 17.8% and the 30 day share price return down 25.35%, even though the 5 year total shareholder return is 29.74%. If you are interested in how other companies are...

Halozyme Therapeutics has more than doubled investors' money over the past five years, yet its valuation checks and current market pricing suggest the stock is not an obvious bargain at today's levels. A 107.1% total return over five years points to strong shareholder gains that raise the bar for what future performance needs to justify. The recent collaboration with Incyte around ENHANZE based subcutaneous INCA033989 can support sentiment on long term revenue potential, while ongoing...

Tenable Holdings (NasdaqGS:TENB) has launched an always-on autonomous agentic fleet for its Hexa AI engine. The new capability supports continuous, automated exposure remediation and security operations within the Tenable One platform. The update represents a shift toward more autonomous security operations for Tenable customers. Tenable Holdings operates in a crowded cybersecurity field where enterprises are trying to manage rising volumes of vulnerabilities, alerts and compliance demands...

With inflation signals mixed, rates under review and energy prices tied to geopolitical risk, many investors are unsure where to look next for potential growth. The High-Quality Undiscovered Gems screener focuses on smaller stocks with strong fundamentals that large institutions may be overlooking. That can help you focus on business quality instead of short term macro headlines. In this article you will see 3 of the stocks from this screener, along with plain English explanations of what...

Global markets are still trying to make sense of sticky inflation, shifting rate expectations and mixed economic data from the US, Europe and Asia. In that kind of backdrop, many investors are looking for sectors where demand is influenced as much by long planning cycles and government priorities as by the latest growth headlines. The Aerospace and Defense screener focuses on companies that manufacture or provide services to these industries, where contracts can be large, complex and long...

In the June 2026 quarter, Provident Financial Services reported earnings of US$0.35 per share and revenue of US$10.59 million, both above analyst estimates. This stronger-than-expected quarterly performance raises questions about how its core banking, digital initiatives, and fee-based businesses may influence its longer-term outlook. We’ll now explore how this earnings and revenue beat could affect Provident Financial Services’ investment narrative and key performance drivers. The latest...

Alibaba Group Holding stock has fallen about 38.0% over the past five years, yet the current checks suggest the shares may now sit at a discount to their intrinsic value estimate and to where simple earnings multiples place the business. A roughly 38.0% share price decline over five years means long term holders have seen value erode. This often pushes investors to re examine whether the current price still reflects the underlying business. On the upside, Alibaba's push into artificial...

Nomad Foods stock has delivered a roughly 47.8% decline over the past five years, yet current valuation checks and an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach both indicate the shares trade at a discount to their assessed worth. That gap sits against a backdrop of recent refinancing plans and softer sales trends that could influence how much of that apparent discount investors are willing to recognize. Over five years the share price has fallen about 47.8%,...